Prof. Ahn Jung-shin of Ewha Womans University Mokdong Hospital has applied for a patent to commercialize a microbial strain with anticancer effects on breast cancer

Dec 24, 2024

Professor Ahn Jung-shin of Surgery at the Institute of Convergence Medicine at Ewha Womans University Mokdong Hospital filed a patent application in March this year to commercialize the 「Human Symbiotic Microbial Strain" with anticancer effects on breast cancer through a patent-only license agreement on the 15th.

This agreement was signed based on cooperation with Ewha Womans University's Industry-Academic Cooperation Group (Director Lee Joon-sung), Konkuk University's Glocal Industry-Academic Cooperation Group (Director Jeon Heung-seok), and LapswiseNet (CEO Jang Jung-woo).

Through the agreement, these universities and companies will promote ▲ patent utilization ▲ technology and human resource exchange between universities and companies ▲ commercialization of research technology.




Professor Ahn emphasized that it has already been proven to be harmless to the human body because it is a symbiotic microorganism obtained from feces of healthy people as well as anticancer effects that directly act on breast cancer.

Professor Ahn Jung-shin "This study laid the foundation for securing new technologies and paved the way for co-prosperity of all through cooperation in industry, academia, research, and medicine."The goal of future research is to more clearly identify the mechanism of action of symbiotic microorganisms on the human body, he said.

Prof. Ahn Jung-shin of Ewha Womans University Mokdong Hospital has applied for a patent to commercialize a microbial strain with anticancer effects on breast cancer
안정신 교수








bellho@sportschosun.com